Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorAIM-EUSEBI, A.
dc.contributor.authorPROTHON, E.
dc.contributor.authorMAJERHOLC, C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBARGER, Diana
dc.contributor.authorYAZDANPANAH, Y.
dc.contributor.authorAUBERT, J. P.
dc.date.accessioned2020-10-19T08:00:10Z
dc.date.available2020-10-19T08:00:10Z
dc.date.issued2018-12
dc.identifier.issn1751-1402 (Electronic) 1381-4788 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/11401
dc.description.abstractEnBACKGROUND: Many people in Europe remain undiagnosed for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV). OBJECTIVES: To evaluate acceptability and effectiveness of a questionnaire designed to facilitate identification of risk factors for these viruses. METHODS: We performed an observational study, in a prospectively enrolled cohort of patients in Paris (France) seen in 2014. Eighteen GPs administered a questionnaire to the first 50 patients, collecting information about risk factors. GPs were randomized into two groups: A (self-administered questionnaire) and B (GP-administered questionnaire). We used the overall response rate to assess the acceptability of the questionnaire. We used the rate of newly identified risk factors and compared the number of tests performed one year before and immediately after the intervention to assess the effectiveness of the questionnaire. RESULTS: 842 patients were randomized: 349 (41.5%) in group A and 493 (58.5%) in group B. Acceptability was 88.5% (95%CI: 86.3-90.6); 93.1% (95%CI: 90.5-95.8) in-group A and 85.2% (95%CI: 82.1-88.3) in group B (P = 0.0004). Prevalence of risk factors was 51.8% (95%CI: 48.2-54.4) and 58.3% were newly identified (95%CI: 52.9-63.7). The number of HIV tests performed during the four weeks after intervention increased by 27% compared to the same period one year before (P = 0.22). It increased by 113% (P = 0.005) and 135% (P = 0.005) for HBV and HCV, respectively. CONCLUSION: The questionnaire proved acceptable and effective in identifying risk factors for HIV, HBV and HCV in general practice.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enMORPH3Eus
dc.title.enThe acceptability and effectiveness of a questionnaire for the identification of risk factors for HIV and hepatitis B and C: An observational study in general practice
dc.title.alternativeEur J Gen Practen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1080/13814788.2017.1400529en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed29172800en_US
bordeaux.journalEuropean Journal of General Practiceen_US
bordeaux.page60-67en_US
bordeaux.volume24en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03163242
hal.version1
hal.date.transferred2021-03-09T09:41:57Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=European%20Journal%20of%20General%20Practice&rft.date=2018-12&rft.volume=24&rft.issue=1&rft.spage=60-67&rft.epage=60-67&rft.eissn=1751-1402%20(Electronic)%201381-4788%20(Linking)&rft.issn=1751-1402%20(Electronic)%201381-4788%20(Linking)&rft.au=AIM-EUSEBI,%20A.&PROTHON,%20E.&MAJERHOLC,%20C.&BARGER,%20Diana&YAZDANPANAH,%20Y.&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée